Answer
After receiving Clariscan (gadoterate meglumine), patients driving or operating machinery should consider that nausea may occur, and no studies of effects on driving or machinery use have been performed.
Sources for this answer
- Clariscan 0.5 mmol/ mL solution for injectionGE Healthcare Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 5Document updated
Sources checked